Tumor-secreted receptor activator of NFkB ligand (RANKL) activates NFkB in astrocytes leading to their producing transforming growth factor β (TGF-β), which stimulates invasion in vivo in xenografts of the glioma cell line U87 [141]. This evidence concerns the gene NFKB1 and central nervous system cancer.